demonstrated that leptin promotes pancreatic tumor growth through altered pathways of STAT3 and PI3K/AKT signaling, whereas AdipoRon inhibits leptin-induced STAT3 activation and pancreatic tumor growth in vivo (70, 71). This evidence concerns the gene AKT1 and pancreatic neoplasm.